122 related articles for article (PubMed ID: 2707703)
1. [Prevention of recurrence in urinary bladder cancer--quo vadis?].
Kriegmair M
Fortschr Med; 1989 Mar; 107(8):14-5. PubMed ID: 2707703
[No Abstract] [Full Text] [Related]
2. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
[TBL] [Abstract][Full Text] [Related]
3. [BCG vaccine and prevention of recurrence of superficial cancer of the bladder. Have all the possibilities been exhausted?].
Vera-Donoso CD; Llopis Minguez B; Gallego Gómez J; Jiménez Cruz JF
Actas Urol Esp; 1989; 13(4):233-5. PubMed ID: 2678933
[No Abstract] [Full Text] [Related]
4. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE
Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581
[No Abstract] [Full Text] [Related]
5. [Intravesical BCG therapy for superficial bladder cancer].
Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
[TBL] [Abstract][Full Text] [Related]
6. [Therapy and prevention of recurrence in bladder cancer. Convincing results].
Urologe A; 1995 Sep; 34(5 Suppl):1-4. PubMed ID: 9131099
[No Abstract] [Full Text] [Related]
7. [Intravesical BCG vaccine in bladder cancer].
Beisland HO; Sander S
Tidsskr Nor Laegeforen; 1989 Jun; 109(17-18):1891-2. PubMed ID: 2749672
[TBL] [Abstract][Full Text] [Related]
8. [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].
Rivera P; Caffarena E; Cornejo H; Del Pino M; Fonerón A; Haemmersli J; Sepúlveda M; Ubilla A
Actas Urol Esp; 1993 Apr; 17(4):243-6. PubMed ID: 8342414
[TBL] [Abstract][Full Text] [Related]
9. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
Sabichi AL; Lerner SP; Atkinson EN; Grossman HB; Caraway NP; Dinney CP; Penson DF; Matin S; Kamat A; Pisters LL; Lin DW; Katz RL; Brenner DE; Hemstreet GP; Wargo M; Bleyer A; Sanders WH; Clifford JL; Parnes HL; Lippman SM
Clin Cancer Res; 2008 Jan; 14(1):224-9. PubMed ID: 18172274
[TBL] [Abstract][Full Text] [Related]
10. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
11. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
[TBL] [Abstract][Full Text] [Related]
12. Rationale for intensive intravesical chemotherapy.
Soloway MS
Prog Clin Biol Res; 1984; 153():287-95. PubMed ID: 6433357
[No Abstract] [Full Text] [Related]
13. [Prophylaxis of superficial bladder cancer with 1 mg of intravesical BCG: comparison with other doses].
Corti Ortíz D; Rivera Garay P; Avilés Jasse J; Hidalgo Carmona F; MacMillan Soto G; Coz Cañas LF; Vargas Delaunoy R; Susaeta Saénz de San Pedro R
Actas Urol Esp; 1993 Apr; 17(4):239-42. PubMed ID: 8342413
[TBL] [Abstract][Full Text] [Related]
14. [Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer].
Varentsov GI; Zakhmatov IuM; Kornev AI; Otvetchikov IN
Urologiia; 1999; (5):29-30. PubMed ID: 11150151
[TBL] [Abstract][Full Text] [Related]
15. [Intracavitary BCG instillation in superficial bladder cancer].
Zhang DY; Xu LX; Zhang JL
Zhonghua Wai Ke Za Zhi; 1986 Nov; 24(11):683-4, 701. PubMed ID: 3568884
[No Abstract] [Full Text] [Related]
16. Advances in the treatment of superficial bladder cancer: optimizing BCG immunotherapy. Introduction.
Lamm DL
Eur Urol; 1995; 27 Suppl 1():1. PubMed ID: 7750524
[No Abstract] [Full Text] [Related]
17. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG].
Wetzel O; Glemain P; Bouchot O; Guillonneau B; Baron M; Buzelin JM; Auvigne J
Prog Urol; 1993; 3(4):595-607. PubMed ID: 8401620
[TBL] [Abstract][Full Text] [Related]
18. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
19. BCG in the management of superficial bladder cancer.
Robinson MR
Prog Clin Biol Res; 1985; 185B():161-6. PubMed ID: 3898140
[No Abstract] [Full Text] [Related]
20. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
Evans CP
Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
